Integra LifeSciences (IART) vs iRadimed (IRMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
iRadimed (IRMD) has outperformed Integra LifeSciences (IART) over the past year, gaining 11.7% versus a loss of 9.9%. Over five years, IRMD leads with a +134.2% price change compared with -80.8% for IART. iRadimed is the larger company by market cap ($1.10 billion vs $1.04 billion), about 1.1 times the size.
On valuation, Integra LifeSciences trades at a lower forward P/E (5.2x vs 35.0x for iRadimed). iRadimed pays a dividend yielding 0.90%, while Integra LifeSciences does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IART | IRMD |
|---|---|---|
| Share price | $13.41 | $85.88 |
| Market cap | $1.04B | $1.10B |
| 1-day change | +3.15% | +0.48% |
| YTD return | +4.67% | -11.72% |
| 1-year return | -9.91% | +11.72% |
| 5-year return | -80.79% | +134.20% |
| P/E ratio (TTM) | — | 47.98 |
| Forward P/E | 5.16 | 35.01 |
| EPS (TTM) | $-0.09 | $1.79 |
| Dividend yield | 0.00% | 0.90% |
| Annual dividend | $0.00 | $0.77 |
| 52-week high | $20.49 | $107.90 |
| 52-week low | $8.70 | $71.34 |
| Distance from 52-week high | -34.55% | -20.41% |
| Analyst consensus | hold | none |
| Avg. price target upside | +37.06% | +37.40% |
| Average volume | 916.55K | 125.83K |
| Shares outstanding | 77.77M | 12.79M |
| Employees | 4,427 | 166 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IRMD has outperformed IART by 21.6 percentage points over the past year.
About Integra LifeSciences
IART stock →Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments.
Health Care · Medical/Dental Instruments · 4,427 employees
About iRadimed
IRMD stock →IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.
Health Care · Medical/Dental Instruments · 166 employees
IART vs IRMD FAQ
Which is bigger, Integra LifeSciences or iRadimed?
iRadimed (IRMD) is larger, with a market capitalization of $1.10B compared with $1.04B for Integra LifeSciences (IART).
Which stock has performed better over the past year, IART or IRMD?
IRMD returned +11.72% over the past 12 months, compared with -9.91% for IART (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Integra LifeSciences or iRadimed?
iRadimed pays a dividend yielding 0.90%, while Integra LifeSciences does not currently pay a regular dividend.
Are Integra LifeSciences and iRadimed in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.